Literature DB >> 19843550

Staging algorithm for diffuse malignant pleural mesothelioma.

Marcin Zielinski1, Jolanta Hauer, Lukasz Hauer, Juliusz Pankowski, Tomasz Nabialek, Artur Szlubowski.   

Abstract

An algorithm of preoperative mediastinal nodal staging with endobronchial/endoesophageal ultrasonography (EBUS/EUS) and transcervical extended mediastinal lymphadenectomy (TEMLA) combined with laparoscopy/peritoneal lavage and cytology was analyzed to establish the realistic criteria for radical multimodality treatment of malignant pleural mesothelioma (MPM). The algorithm included computed tomography (CT), thoracoscopy with multiple pleural biopsies and talc pleurodesis, EBUS/EUS and one-stage TEMLA and laparoscopy/peritoneal lavage and cytology of the fluid. Forty-two patients were diagnosed from 1 January 2004 to 31 December 2008. There were 16 women and 26 men in ages ranging from 43 to 77 years (mean 57.8); 31 epithelioid, 2 sarcomatoid and 9 biphasic type MPM. 21/42 patients were considered possible candidates for multimodality treatment. Three patients who received neoadjuvant chemotherapy were excluded from this study. EBUS/EUS was performed to stage the mediastinal nodes. In 3/18 patients metastatic nodes were discovered. In the rest of the 15 patients simultaneous TEMLA and laparoscopy/peritoneal lavage and cytology of the fluid were performed. In three patients TEMLA was positive, in six patients laparoscopy was positive and in two patients both TEMLA and laparoscopy were positive. Finally, 4/42 (9.5%) patients underwent thoracotomy with one exploration (chest wall infiltration) and three pleuropneumonectomies with the subsequent chemo- and radiotherapy. The proposed algorithm of preoperative staging spared the majority of MPM patients from futile surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19843550     DOI: 10.1510/icvts.2009.213611

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  5 in total

Review 1.  Malignant pleural mesothelioma: predictors and staging.

Authors:  William G Richards
Journal:  Ann Transl Med       Date:  2017-06

2.  Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients.

Authors:  David J Sugarbaker; William G Richards; Raphael Bueno
Journal:  Ann Surg       Date:  2014-10       Impact factor: 12.969

3.  Endobronchial ultrasound-guided transbronchial needle aspiration mediastinal lymph node staging in malignant pleural mesothelioma.

Authors:  Kasia Czarnecka-Kujawa; Marc de Perrot; Shaf Keshavjee; Kazuhiro Yasufuku
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

4.  Thoracic computed tomography findings in malignant mesothelioma.

Authors:  Omer Tamer Dogan; Ismail Salk; Fikret Tas; Kursat Epozturk; Cesur Gumus; Ibrahim Akkurt; Sefa Levent Ozsahin
Journal:  Iran J Radiol       Date:  2012-11-20       Impact factor: 0.212

5.  Does size matter? -a population-based analysis of malignant pleural mesothelioma.

Authors:  Jiaxi He; Songhui Xu; Hui Pan; Shuben Li; Jianxing He
Journal:  Transl Lung Cancer Res       Date:  2020-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.